CanSino AH shares rise together: A-shares rose over 16%, H-shares rose nearly 14%, both hitting record highs.

Vaccine stocks continue to be active, with CanSino Biologics' A-shares rising in the afternoon, with A-shares rising by over 16% to 82.48 yuan at one point, reaching a new high since December 2023; H-shares rose nearly 14% to 48.55 Hong Kong dollars, reaching a new high since March 2023. On the news front, the outbreak of chikungunya fever in Foshan City, Guangdong continues to be the focus of the market's attention. According to the Guangdong Provincial Center for Disease Control and Prevention, from 0:00 on July 20, 2025 to 24:00 on July 26, Guangdong Province reported 2940 new cases of locally transmitted chikungunya fever, with no reports of severe cases or deaths. The cases were distributed as follows: 2882 cases in Foshan, 22 cases in Guangzhou, 18 cases in Zhongshan, 3 cases each in Dongguan, Zhuhai, and Heyuan, 2 cases each in Jiangmen, Yangjiang, and Zhaoqing, and 1 case each in Qingyuan, Shenzhen, and Zhanjiang. With the increasing number of confirmed cases and the warning issued by experts from the World Health Organization, the market's demand for related vaccines is significantly increasing, stimulating vaccine stocks to attract funds.